FDA approval summary for lonafarnib (Zokinvy) for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies-Reference-Cited by-同舟云学术

FDA approval summary for lonafarnib (Zokinvy) for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies

Published:2023-02 Issue:2 Volume:25 Page:100335
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Suzuki Mari^ORCID,Jeng Linda J.B.,Chefo Solomon,Wang Yan,Price Dionne,Li Xiaohui,Wang Jie,Li Ruo-Jing,Ma Lian,Yang Yuching,Zhang Xinyuan,Zheng Nan,Zhang Ke,Joseph David B.,Shroff Hitesh,Doan Jenny,Pacanowski Michael,Smpokou Patroula,Donohue Kathleen,Joffe Hylton V.

Publisher

Elsevier BV

Subject

Genetics (clinical)

Reference13 articles.

1. Association of lonafarnib treatment vs no treatment with mortality rate in patients with Hutchinson-Gilford progeria syndrome;Gordon;JAMA,2018

2. Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome;Gordon;Circulation,2014

3. New approaches to progeria;Kieran;Pediatrics,2007

4. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes;Toth;Proc Natl Acad Sci U S A,2005

5. A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria;Fong;Science,2006

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling;Cell Chemical Biology;2024-07

2. Intervention for critical aortic stenosis in Hutchinson-Gilford progeria syndrome;Frontiers in Cardiovascular Medicine;2024-04-25

3. Protein lipidation in health and disease: molecular basis, physiological function and pathological implication;Signal Transduction and Targeted Therapy;2024-03-15

4. Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors;British Journal of Cancer;2024-01-26

5. Epidemiological characteristics of patients with Hutchinson-Gilford progeria syndrome and progeroid laminopathies in China;Pediatric Research;2024-01-08